---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-032838"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2026-08-13T20:38:45+00:00"
generated_at: "2026-08-13T20:40:08.850324+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuwellis Q2 net sales up 14% to $2.0M; gross margin 76% vs 56%; CEO appointed

## Summary
- Net sales $2.0M, +14% YoY; U.S. revenue +17%; H1 sales $4.4M, +20%.
- Gross margin improved to 76% from 56% on pricing, mix, contract manufacturing.
- Net loss $4.8M incl. $1.7M non-cash warrant expense; cash $3.9M at June 30.
- Raised ~$12.7M gross proceeds from June offering and July financing/warrant exercises.
- Appointed Mike McCormick CEO effective June 30; FDA pre-sub for Aquadex label to 5kg.

## SEC filing metadata
- accession: 0001140361-26-032838
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2026-08-13T20:38:45+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036126032838/0001140361-26-032838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036126032838/ef20080204_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-032838
- JSON: https://secwatch.observer/filing/0001140361-26-032838.json
- Plain text: https://secwatch.observer/filing/0001140361-26-032838.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.